Antibiotic Bootcamps for Developers

A collaborative project of CARB-Xed, GARDP, ASM, and ESCMID

5-8 September 2017, ASM-ESCMID Conference, Boston

Moderator: Judith Steenbergen, Paratek Pharmaceuticals


Erika Matuschek, EUCAST: Investigational New Drug – Groundwork for in vitro antimicrobial susceptibility testing

Kevin Krause, Achaogen: NDA Requirements: Surveillance, Clinical Trial Data, Breakpoints

Robin Patel, Mayo Clinic: Making Antibacterial Susceptibility Available in Clinical Practice

Roundtable: Pitfalls in Development

Date : September 5th, 2017